Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
This approval is based on results obtained from three clinical studies in more than 500 Japanese patients with anemia of CKD not on dialysis... Nov 27
first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia... Oct 31
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ... Oct 29
HBI-8000 for Monotherapy Adult T-cell Leukemia-Lymphoma ATL ... Oct 01
Novavax partners with Takeda for manufacturing and marketing covid vaccine in Japan... Aug 08
... Aug 01
ILUMYA is one of the key specialty products of Sun Pharma... Jun 29
Marketing approval for Merz’s Xeomin Botulinum toxin Type A in Japan... Jun 29
Under the licensing agreements, the companies have a right to receive a technology transfer of the Gilead Sciences manufacturing process for remdesivir to enable them ... May 13
New subgroup analyses for first-line treatment of advanced renal cell carcinoma with BAVENCIO®* (avelumab) in combination with axitinib... Sep 23
Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study Phase II INSIGHT 2 study now open for enrollment for ... Sep 12
Investigational oral MET inhibitor has previously received SAKIGAKE 'fast-track' regulatory designation in Japan - MET exon 14 skipping alterations and MET amplifications are present in ... Sep 11
-Advertisements-
Thursday, April 25, 2024
